The clearance was granted after two phase III studies that showed significant visual acuity improvement with EYLEA.
EYLEA was first approved to treat wet age-related Macular Degeneration.
More Articles on Ophthalmology:
Ophthalmologist Dr. George Primbs Recognized for Community Service
Glaucoma, Cataract Specialist Dr. Charles Weber Joins The Eye Institute of Utah
Eye Care Product Maker Akorn to Acquire Hi-Tech Pharmacal for $640M
